{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T01:06:53Z","timestamp":1779325613492,"version":"3.51.4"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2022-136909OB-I00"],"award-info":[{"award-number":["PID2022-136909OB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2019-104366RB-C21"],"award-info":[{"award-number":["PID2019-104366RB-C21"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2019-110405RB-I00"],"award-info":[{"award-number":["PID2019-110405RB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2022-137214OB-C21"],"award-info":[{"award-number":["PID2022-137214OB-C21"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["CB\/11\/00222"],"award-info":[{"award-number":["CB\/11\/00222"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003339","name":"Spanish National Research Council","doi-asserted-by":"publisher","award":["2023AEP049"],"award-info":[{"award-number":["2023AEP049"]}],"id":[{"id":"10.13039\/501100003339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["CB\/11\/00222"],"award-info":[{"award-number":["CB\/11\/00222"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006049","name":"Comisi\u00f3n Sectorial de Investigaci\u00f3n Cient\u00edfica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006541","name":"Community of Madrid Ministry of Health","doi-asserted-by":"publisher","award":["P2022\/BMD-7225"],"award-info":[{"award-number":["P2022\/BMD-7225"]}],"id":[{"id":"10.13039\/501100006541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006541","name":"Community of Madrid Ministry of Health","doi-asserted-by":"publisher","award":["S2022\/BMD-7223"],"award-info":[{"award-number":["S2022\/BMD-7223"]}],"id":[{"id":"10.13039\/501100006541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejphar.2025.178281","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T06:41:52Z","timestamp":1761201712000},"page":"178281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Indole-3-carbinol is an inhibitor of KV1.3 potassium voltage-gated channel activity in chronic lymphocytic leukemia cells"],"prefix":"10.1016","volume":"1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5960-2271","authenticated-orcid":false,"given":"Maria","family":"Baena-Nuevo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4040-1920","authenticated-orcid":false,"given":"Alba","family":"Vera-Zambrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Martinez-Laperche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismael","family":"Bu\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Mu\u00f1oz-Calleja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3929-1960","authenticated-orcid":false,"given":"Carmen","family":"Valenzuela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0110-0009","authenticated-orcid":false,"given":"Juan Manuel","family":"Zapata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2081-0882","authenticated-orcid":false,"given":"Gema","family":"Perez-Chacon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.178281_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0092-8674(00)80728-X","article-title":"MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia","volume":"97","author":"Abbott","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2025.178281_bib2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jiac.2015.10.001","article-title":"Anti-cancer and cardioprotective effects of indol-3-carbinol in doxorubicin-treated mice","volume":"22","author":"Adwas","year":"2016","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.ejphar.2025.178281_bib3","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.4161\/cc.4.9.1993","article-title":"Molecular targets and anticancer potential of indole-3-carbinol and its derivatives","volume":"4","author":"Aggarwal","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejphar.2025.178281_bib4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00210-006-0118-6","article-title":"Open channel block of Kv1.3 by rosiglitazone and troglitazone: kv1.3 as the pharmacological target for rosiglitazone","volume":"374","author":"Ahn","year":"2007","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.ejphar.2025.178281_bib5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/gyno.2000.5847","article-title":"Placebo-controlled trial of indole-3-carbinol in the treatment of CIN","volume":"78","author":"Bell","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ejphar.2025.178281_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2024.100809","article-title":"Proximity labeling proteomics reveals Kv1.3 potassium channel immune interactors in Microglia","volume":"23","author":"Bowen","year":"2024","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.ejphar.2025.178281_bib7","first-page":"387","article-title":"Diindolylmethane (DIM) spontaneously forms from indole-3-carbinol (I3C) during cell culture experiments","volume":"24","author":"Bradlow","year":"2010","journal-title":"In Vivo"},{"key":"10.1016\/j.ejphar.2025.178281_bib8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1023\/A:1010958907271","article-title":"Molecular properties and physiological roles of ion channels in the immune system","volume":"21","author":"Cahalan","year":"2001","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.ejphar.2025.178281_bib9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3389\/fphys.2013.00283","article-title":"The voltage-dependent K(+) channels Kv1.3 and Kv1.5 in human cancer","volume":"4","author":"Comes","year":"2013","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ejphar.2025.178281_bib10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cbpa.2017.02.015","article-title":"Peptide blockers of K(v)1.3 channels in T cells as therapeutics for autoimmune disease","volume":"38","author":"Chandy","year":"2017","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ejphar.2025.178281_bib11","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1021\/jf020125i","article-title":"Isolation and structure elucidation of a new thermal breakdown product of glucobrassicin, the parent indole glucosinolate","volume":"50","author":"Chevolleau","year":"2002","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejphar.2025.178281_bib12","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a035220","article-title":"Chronic lymphocytic leukemia","volume":"11","author":"Chiorazzi","year":"2021","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ejphar.2025.178281_bib13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0009-2797(91)90090-T","article-title":"Structure elucidation of acid reaction products of indole-3-carbinol: detection in vivo and enzyme induction in vitro","volume":"80","author":"De Kruif","year":"1991","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2025.178281_bib14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0008-6363(97)00121-1","article-title":"Block of human cardiac Kv1.5 channels by loratadine: voltage-, time- and use-dependent block at concentrations above therapeutic levels","volume":"35","author":"Delpon","year":"1997","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2025.178281_bib15","article-title":"Modification by KCNE1 variants of the hERG potassium channel response to premature stimulation and to pharmacological inhibition","volume":"1","author":"Du","year":"2013","journal-title":"Phys. Rep."},{"key":"10.1016\/j.ejphar.2025.178281_bib16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.annonc.2020.09.019","article-title":"Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Eichhorst","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejphar.2025.178281_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.211","article-title":"Human mesenchymal stem cell-replicative senescence and oxidative stress are closely linked to aneuploidy","volume":"4","author":"Estrada","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2025.178281_bib18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00702-015-1446-9","article-title":"Normal human CD4(+) helper T cells express Kv1.1 voltage-gated K(+) channels, and selective Kv1.1 block in T cells induces by itself robust TNFalpha production and secretion and activation of the NFkappaB non-canonical pathway","volume":"123","author":"Fellerhoff-Losch","year":"2016","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejphar.2025.178281_bib19","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nri3233","article-title":"Ion channels and transporters in lymphocyte function and immunity","volume":"12","author":"Feske","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2025.178281_bib20","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1161\/01.RES.81.6.1053","article-title":"Molecular determinants of stereoselective bupivacaine block of hKv1.5 channels","volume":"81","author":"Franqueza","year":"1997","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2025.178281_bib21","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0008-6363(98)00220-X","article-title":"Functional expression of an inactivating potassium channel (Kv4.3) in a mammalian cell line","volume":"41","author":"Franqueza","year":"1999","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2025.178281_bib22","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0022-3565(24)38774-9","article-title":"Effects of bupivacaine and a novel local anesthetic, IQB-9302, on human cardiac K+ channels","volume":"296","author":"Gonzalez","year":"2001","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2025.178281_bib23","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.biopha.2018.02.088","article-title":"Prevention of doxorubicin (DOX)-induced genotoxicity and cardiotoxicity: effect of plant derived small molecule indole-3-carbinol (I3C) on oxidative stress and inflammation","volume":"101","author":"Hajra","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2025.178281_bib24","doi-asserted-by":"crossref","first-page":"44151","DOI":"10.1074\/jbc.M112.372540","article-title":"Cortactin controls surface expression of the voltage-gated potassium channel K(V)10.1","volume":"287","author":"Herrmann","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.178281_bib25","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.18632\/oncotarget.27122","article-title":"Expression and function of Kv1.3 channel in malignant T cells in Sezary syndrome","volume":"10","author":"Hu","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2025.178281_bib26","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s11864-022-00974-0","article-title":"New treatment options for newly-diagnosed and relapsed chronic lymphocytic leukemia","volume":"23","author":"Iskierka-Jazdzewska","year":"2022","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.ejphar.2025.178281_bib27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2010.10.066","article-title":"Anti-proliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo","volume":"651","author":"Jang","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178281_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2012.02.070","article-title":"Sigma-1 receptor alters the kinetics of Kv1.3 voltage gated potassium channels but not the sensitivity to receptor ligands","volume":"1452","author":"Kinoshita","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2025.178281_bib29","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/emmm.201200235","article-title":"Inhibitors of mitochondrial Kv1.3 channels induce Bax\/Bak-independent death of cancer cells","volume":"4","author":"Leanza","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ejphar.2025.178281_bib30","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.bbamcr.2015.11.032","article-title":"Pharmacological targeting of ion channels for cancer therapy: in vivo evidences","volume":"1863","author":"Leanza","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2025.178281_bib31","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccell.2017.03.003","article-title":"Direct pharmacological targeting of a mitochondrial ion channel selectively kills tumor cells in vivo","volume":"31","author":"Leanza","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejphar.2025.178281_bib32","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/leu.2013.56","article-title":"Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia","volume":"27","author":"Leanza","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.ejphar.2025.178281_bib33","article-title":"Indole-3-Carbinol (I3C) protects the heart from Ischemia\/Reperfusion Injury by inhibiting oxidative stress, inflammation, and cellular apoptosis in mice","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178281_bib34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41421-021-00269-y","article-title":"Structures of wild-type and H451N mutant human lymphocyte potassium channel K(V)1.3","volume":"7","author":"Liu","year":"2021","journal-title":"Cell Discov"},{"key":"10.1016\/j.ejphar.2025.178281_bib35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1113\/jphysiol.2003.046045","article-title":"Mutant MiRP1 subunits modulate HERG K+ channel gating: a mechanism for pro-arrhythmia in long QT syndrome type 6","volume":"551","author":"Lu","year":"2003","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2025.178281_bib36","doi-asserted-by":"crossref","first-page":"7443","DOI":"10.1074\/jbc.275.11.7443","article-title":"Differential targeting of shaker-like potassium channels to lipid rafts","volume":"275","author":"Martens","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.178281_bib37","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.repbio.2018.07.002","article-title":"Comparison of dienogest effects upon 3,3'-diindolylmethane supplementation in models of endometriosis and clinical cases","volume":"18","author":"Morales-Prieto","year":"2018","journal-title":"Reprod. Biol."},{"key":"10.1016\/j.ejphar.2025.178281_bib38","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0278-6915(03)00004-8","article-title":"Indole-3-carbinol and 3,3'-diindolylmethane induce apoptosis in human prostate cancer cells","volume":"41","author":"Nachshon-Kedmi","year":"2003","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejphar.2025.178281_bib39","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1136\/ijgc-00009577-200603000-00050","article-title":"A randomized phase II trial of indole-3-carbinol in the treatment of vulvar intraepithelial neoplasia","volume":"16","author":"Naik","year":"2006","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ejphar.2025.178281_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15102716","article-title":"The phosphorylation of Kv1.3: a modulatory mechanism for a multifunctional ion channel","volume":"15","author":"Navarro-Perez","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejphar.2025.178281_bib41","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3389\/fphar.2020.00489","article-title":"hERG K(+) channels promote survival of irradiated leukemia cells","volume":"11","author":"Palme","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178281_bib42","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.2174\/138161206777585120","article-title":"K+ channel blockers: novel tools to inhibit T cell activation leading to specific immunosuppression","volume":"12","author":"Panyi","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2025.178281_bib43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrc3635","article-title":"The roles of K(+) channels in cancer","volume":"14","author":"Pardo","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejphar.2025.178281_bib44","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3390\/md13010529","article-title":"Development of highly selective Kv1.3-blocking peptides based on the sea anemone peptide ShK","volume":"13","author":"Pennington","year":"2015","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejphar.2025.178281_bib45","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.phrs.2014.08.005","article-title":"Indole-3-carbinol induces cMYC and IAP-family downmodulation and promotes apoptosis of Epstein-Barr virus (EBV)-positive but not of EBV-negative Burkitt's lymphoma cell lines","volume":"89","author":"Perez-Chacon","year":"2014","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2025.178281_bib46","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1158\/1078-0432.CCR-15-0736","article-title":"Indole-3-Carbinol synergizes with and restores Fludarabine sensitivity in chronic lymphocytic leukemia cells irrespective of p53 activity and treatment resistances","volume":"22","author":"Perez-Chacon","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2025.178281_bib47","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3389\/fonc.2017.00239","article-title":"Regulation of proliferation by a mitochondrial potassium channel in pancreatic ductal adenocarcinoma cells","volume":"7","author":"Peruzzo","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejphar.2025.178281_bib48","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2025.178281_bib49","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/leu.2014.26","article-title":"Differential expression of hERG1A and hERG1B genes in pediatric acute lymphoblastic leukemia identifies different prognostic subgroups","volume":"28","author":"Pillozzi","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.ejphar.2025.178281_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e08989","article-title":"Anti-inflammatory, antioxidant, antihypertensive, and antiarrhythmic effect of indole-3-carbinol, a phytochemical derived from cruciferous vegetables","volume":"8","author":"Prado","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.ejphar.2025.178281_bib51","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1158\/1055-9965.EPI-06-0396","article-title":"Single-dose and multiple-dose administration of indole-3-carbinol to women: pharmacokinetics based on 3,3'-diindolylmethane","volume":"15","author":"Reed","year":"2006","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.ejphar.2025.178281_bib52","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1158\/1055-9965.EPI-05-0121","article-title":"A phase I study of indole-3-carbinol in women: tolerability and effects","volume":"14","author":"Reed","year":"2005","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.ejphar.2025.178281_bib53","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jvoice.2003.05.005","article-title":"Indole-3-carbinol for recurrent respiratory papillomatosis: long-term results","volume":"18","author":"Rosen","year":"2004","journal-title":"J. Voice"},{"key":"10.1016\/j.ejphar.2025.178281_bib54","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1038\/s41467-022-31285-5","article-title":"Structures of the T cell potassium channel Kv1.3 with immunoglobulin modulators","volume":"13","author":"Selvakumar","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2025.178281_bib55","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13046-022-02249-w","article-title":"Pharmacological modulation of Kv1.3 potassium channel selectively triggers pathological B lymphocyte apoptosis in vivo in a genetic CLL model","volume":"41","author":"Severin","year":"2022","journal-title":"J. Exp. Clin. Cancer Res. : CR"},{"key":"10.1016\/j.ejphar.2025.178281_bib56","doi-asserted-by":"crossref","first-page":"18528","DOI":"10.1074\/jbc.M200592200","article-title":"Functional up-regulation of HERG K+ channels in neoplastic hematopoietic cells","volume":"277","author":"Smith","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.178281_bib57","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1085\/jgp.101.4.513","article-title":"A rapidly activating and slowly inactivating potassium channel cloned from human heart. Functional analysis after stable mammalian cell culture expression","volume":"101","author":"Snyders","year":"1993","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.ejphar.2025.178281_bib58","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/01.RES.77.3.575","article-title":"Determinants of antiarrhythmic drug action. Electrostatic and hydrophobic components of block of the human cardiac hKv1.5 channel","volume":"77","author":"Snyders","year":"1995","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2025.178281_bib59","doi-asserted-by":"crossref","first-page":"14861","DOI":"10.1073\/pnas.0804236105","article-title":"Mitochondrial potassium channel Kv1.3 mediates Bax-induced apoptosis in lymphocytes","volume":"105","author":"Szabo","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2025.178281_bib60","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1159\/000430223","article-title":"Biophysical characterization and expression analysis of Kv1.3 potassium channel in primary human leukemic B cells","volume":"37","author":"Szabo","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ejphar.2025.178281_bib61","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10549-017-4292-7","article-title":"A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen","volume":"165","author":"Thomson","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ejphar.2025.178281_bib62","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/nutrit\/nuw010","article-title":"Chemopreventive properties of 3,3'-diindolylmethane in breast cancer: evidence from experimental and human studies","volume":"74","author":"Thomson","year":"2016","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.ejphar.2025.178281_bib63","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2113536119","article-title":"Rearrangement of a unique Kv1.3 selectivity filter conformation upon binding of a drug","volume":"119","author":"Tyagi","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2025.178281_bib64","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1074\/jbc.271.5.2406","article-title":"Functional differences in Kv1.5 currents expressed in mammalian cell lines are due to the presence of endogenous Kv beta 2.1 subunits","volume":"271","author":"Uebele","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.178281_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000933","article-title":"Differential association between HERG and KCNE1 or KCNE2","volume":"2","author":"Um","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2025.178281_bib66","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/01.CIR.94.3.562","article-title":"Class III antiarrhythmic effects of zatebradine. Time-, state-, use-, and voltage-dependent block of hKv1.5 channels","volume":"94","author":"Valenzuela","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2025.178281_bib67","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1189\/jlb.0213094","article-title":"Emerging role for the voltage-dependent K+ channel Kv1.5 in B-lymphocyte physiology: expression associated with human lymphoma malignancy","volume":"94","author":"Vallejo-Gracia","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ejphar.2025.178281_bib68","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000480643","article-title":"Targeting the potassium channel Kv1.3 kills glioblastoma cells","volume":"25","author":"Venturini","year":"2017","journal-title":"Neurosignals"},{"key":"10.1016\/j.ejphar.2025.178281_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/membranes12080749","article-title":"Diindolylmethane derivatives: new selective blockers for T-Type calcium channels","volume":"12","author":"Wang","year":"2022","journal-title":"Membranes"},{"key":"10.1016\/j.ejphar.2025.178281_bib70","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.canlet.2008.01.033","article-title":"Indole-3-carbinol as a chemopreventive and anti-cancer agent","volume":"262","author":"Weng","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2025.178281_bib71","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/bph.12967","article-title":"Kv 11.1 (hERG)-induced cardiotoxicity: a molecular insight from a binding kinetics study of prototypical Kv 11.1 (hERG) inhibitors","volume":"172","author":"Yu","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178281_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.687007","article-title":"Molecular insights into the gating kinetics of the Cardiac hERG Channel, illuminated by structure and molecular dynamics","volume":"12","author":"Zequn","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178281_bib73","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/mol.110.064014","article-title":"Potassium channel block by a tripartite complex of two cationophilic ligands and a potassium ion","volume":"78","author":"Zimin","year":"2010","journal-title":"Mol. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925010350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925010350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:31:02Z","timestamp":1779323462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925010350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":73,"alternative-id":["S0014299925010350"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178281","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indole-3-carbinol is an inhibitor of KV1.3 potassium voltage-gated channel activity in chronic lymphocytic leukemia cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178281","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"178281"}}